Update on the management of chemotherapy-induced nausea and vomiting – focus on palonosetron
Michelle Zhou, Marko Popovic, Mark Pasetka, Natalie Pulenzas, Soha Ahrari, Edward Chow, Carlo DeAngelis Department of Pharmacy, Odette Cancer Center, Sunnybrook Health Sciences Center, University of Toronto, Toronto, ON, Canada Purpose: Nausea and vomiting are major adverse effects of che...
Main Authors: | Zhou M, Popovic M, Pasetka M, Pulenzas N, Ahrari S, Chow E, DeAngelis C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-05-01
|
Series: | Therapeutics and Clinical Risk Management |
Online Access: | http://www.dovepress.com/update-on-the-management-of-chemotherapy-induced-nausea-and-vomiting-n-peer-reviewed-article-TCRM |
Similar Items
-
Palonosetron for the prevention of chemotherapy-induced nausea and vomiting: approval and efficacy
by: Rudolph M Navari
Published: (2009-12-01) -
Management of postoperative nausea and vomiting: focus on palonosetron
by: Neil A Muchatuta, et al.
Published: (2008-11-01) -
Management of acute and delayed chemotherapy-induced nausea and vomiting: role of netupitant–palonosetron combination
by: Janicki PK
Published: (2016-05-01) -
Prevention of acute chemotherapy-induced nausea and vomiting: the role of palonosetron
by: Emilio Bajetta, et al.
Published: (2009-08-01) -
Palonosetron in the management of chemotherapy- induced nausea and vomiting in patients receiving multiple-day chemotherapy
by: Affronti ML, et al.
Published: (2014-09-01)